Research

An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice. Read More

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants. Read More

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

Vanderbilt’s eight newest endowed chair holders were recognized by Interim Chancellor and Provost Susan R. Wente, deans, colleagues, family members and donors Sept. 16 at the Student Life Center. Read More

Live cell imaging studies have revealed that microvilli — finger-like protrusions on the surface of epithelial cells — move and collide as they form the brush border. Read More

VUMC's Eric Gamazon has received a Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH. Read More

A new study published by Vanderbilt mechanobiology researchers details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery – thanks to an antibody initially developed for rheumatoid arthritis.  Read More

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk. Read More

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study. Read More

Directors and managers of postdoctoral offices from universities across the U.S. met at Vanderbilt Sept. 5–7 to discuss research findings related to a national study of postdoctoral fellows, including those at Vanderbilt and fellows of Vanderbilt’s Academic Pathways initiative. Read More

A special webinar on federal funding from the Department of Energy is scheduled for Thursday, Sept. 26, from 2 to 3 p.m. in the Baker Building, Room 800C. Remote viewing will be available with advanced registration. Register here to attend the webinar in person or remotely. “DOE and Biological Sciences” will cover a broad range of... Read More

New research from a group of Vanderbilt biomedical engineers reveals that while cancer cells metastasize quickly, they generally choose pathways that use the least amount of energy. Read More

A $3 million NSF grant will establish a new graduate program to train students focused on innovations connecting workforce needs to the talents of neurodiverse individuals. Read More

Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis. Read More

A protein with important functions in astrocytes — star-shaped brain support cells — may alter neuronal excitability and contribute to seizure activity, Vanderbilt researchers report. Read More

New technique for manipulating graphene opens the door to new breakthroughs in quantum technology. Read More

Vanderbilt researchers have discovered that a protein called SGK1 in immune cells is activated by sodium, leading to the development of salt-sensitive hypertension. Read More

Understanding the dynamic regulation of cytoskeletal microtubules may suggest new ways to treat disorders ranging from Alzheimer's disease to cancer. Read More

According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans. Read More

Participate in this study. Vanderbilt University has been awarded a $3.2 million grant by the National Institutes of Health to better understand how children who are deaf or hard of hearing excel at reading. Millions of children are hearing impaired and these individuals tend to have below-average… Read More